NIOX Competitors and Similar CompaniesClear all
NIOX's competitors and similar companies include Zogenix.
 NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | |
Founding Date | Founding Date 2006 | Founding Date 2006 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Emeryville, US HQ Maidenhead, GB |
Employees | Employees 91 | Employees 743% increase |
Financial | ||
Revenue (est.) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) $81.7m (FY, 2021) |
Cost of goods | Cost of goods £11.1m (FY, 2025) | Cost of goods $4.8m (FY, 2021) |
Net income | Net income £7m (FY, 2025) | Net income ($227.4m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company